racemetirosine has been researched along with Metastase in 3 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Excerpt | Relevance | Reference |
---|---|---|
"The highest IMT uptake was found in a metastasis of lung carcinoma." | 1.31 | I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours. ( Franzius, Ch; Matheja, P; Palkovic, S; Rickert, Ch; Riemann, B; Schober, O; Weckesser, M, 2002) |
"With 123I-AMT-SPECT 8/10 metastases in the thorax > 1." | 1.30 | [123I-alpha-methyltyrosine scintigraphy in malignant melanoma]. ( Böni, R; Capaul, R; Huch-Böni, RA; Steinert, H; von Schulthess, GK; Westera, G, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matheja, P | 1 |
Weckesser, M | 1 |
Rickert, Ch | 1 |
Franzius, Ch | 1 |
Palkovic, S | 1 |
Riemann, B | 1 |
Schober, O | 1 |
Steinert, H | 1 |
Böni, R | 1 |
Huch-Böni, RA | 1 |
Capaul, R | 1 |
von Schulthess, GK | 1 |
Westera, G | 1 |
Sunaga, Y | 1 |
Taniguchi, N | 1 |
Hayashi, K | 1 |
Koito, M | 1 |
Inada, M | 1 |
Oyaizu, N | 1 |
Shikata, N | 1 |
3 other studies available for racemetirosine and Metastase
Article | Year |
---|---|
I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours.
Topics: Adult; Aged; alpha-Methyltyrosine; Biological Transport; Biopsy; Brain Neoplasms; Female; Glioma; Hu | 2002 |
[123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
Topics: Adult; Aged; alpha-Methyltyrosine; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose | 1997 |
[An autopsy case of extra-adrenal malignant pheochromocytoma].
Topics: Adult; alpha-Methyltyrosine; Catecholamines; Combined Modality Therapy; Female; Humans; Methyltyrosi | 1990 |